Evidence map›Paper›PMID 38802394›Full record

ArticleScientific reports2024

Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection.

Asmaa Samy, Afnan Hassan, Nesrine M Hegazi, Mai Farid, Moustafa Elshafei

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Asmaa SamyZewail City of Science and Technology, Giza, 12578, Egypt.
Afnan HassanBiomedical Sciences Program, Zewail City of Science and Technology, Giza, 12578, Egypt.
Nesrine M HegaziDepartment of Phytochemistry and Plant Systematics, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Cairo, 12622, Egypt.
Mai FaridDepartment of Phytochemistry and Plant Systematics, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Cairo, 12622, Egypt.
Moustafa ElshafeiZewail City of Science and Technology, Giza, 12578, Egypt. moelshafei@zewailcity.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is a global pandemic that caused a dramatic loss of human life worldwide, leading to accelerated research for antiviral drug discovery. Herbal medicine is one of the most commonly used alternative medicine for the prevention and treatment of many conditions including respiratory system diseases. In this study, a computational pipeline was employed, including network pharmacology, molecular docking simulations, and molecular dynamics simulations, to analyze the common phytochemicals of ginger rhizomes and identify candidate constituents as viral inhibitors. Furthermore, experimental assays were performed to analyze the volatile and non-volatile compounds of ginger and to assess the antiviral activity of ginger oil and hydroalcoholic extract. Network pharmacology analysis showed that ginger compounds target human genes that are involved in related cellular processes to the viral infection. Docking analysis highlighted five pungent compounds and zingiberenol as potential inhibitors for the main protease (M

Indexed as

Antiviral AgentsCOVID-19 Drug TreatmentMolecular Docking SimulationMolecular Dynamics SimulationPlant ExtractsSARS-CoV-2Zingiber officinaleAngiotensin-Converting Enzyme 2Coronavirus 3C ProteasesCOVID-19HumansNetwork PharmacologySpike Glycoprotein, Coronavirus3C-like proteinase, SARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2Antiviral AgentsCoronavirus 3C ProteasesPlant ExtractsSpike Glycoprotein, CoronavirusCOVID-19GingerMolecular docking simulationsMolecular dynamics simulationsNetwork analysisSARS-CoV-2

Identifiers

PMID38802394
PMCPMC11130167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.